Xeris Biopharma Holdings Inc (XERS)

Finanzdaten der Xeris Biopharma Holdings Inc-Aktie (XERS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.79%92.10	83.13	85.81	74.38	71.54
	14.85%61.04	53.14	-	-	-
Selling, General, and Administrative	14.85%61.04	53.14	-	-	-
Research and Development	21.47%10.67	8.78	-	-	-
Operating Income/Loss	34.65%5.17	7.92	16.77	6.73	4.48
Income Tax Expense/Benefit	-	-	-	-	-
	1,492%-31.10	2.23	11.08	0.62	-1.93
Attributable To Parent	1,492%-31.10	2.23	11.08	0.62	-1.93
Basic Average Shares	1.35%172.82	170.52	1.87	163.65	159.46
Diluted Average Shares	2.71%172.82	177.63	14.18	177.62	159.46
Basic Earnings Per Share	1,900%-0.18	0.01	0.07	-	-0.01
Diluted Earnings Per Share	1,900%-0.18	0.01	0.07	-	-0.01